BACKGROUND: Chemotherapy-induced nausea, vomiting, and retching are recognized as having an impact on patients' overall physical well-being, quality of life, and treatment decisions. Although there are many tools available to measure aspects of these symptoms, few offer a complete and concise clinical assessment. OBJECTIVE: The purpose of this article was to provide a comprehensive overview of the various instruments available for the assessment of cancer-related nausea, vomiting, and retching. Analysis included symptoms measured, period evaluated, type of questions posed, and aspects of each symptom measured. METHODS: Searches were conducted to find relevant articles using nationally recognized oncology Web sites and 4 electronic databases including PubMed, MEDLINE/CINAHL and CINAHL/EBSCO, and Cochrane. RESULTS: This review includes a total of 25 instruments that were identified as meeting the inclusion criteria of having been developed, or adapted, for the adult population, with an oncology focus. CONCLUSION: The ideal instrument would include measurement of all 3 symptoms while remaining clear, concise, and clinically relevant. IMPLICATIONS FOR PRACTICE: Although only 1 instrument came close to meeting these criteria, this review provides nurses with specific information on a variety of instruments to assist providers in selecting the most appropriate instrument for their specific clinical setting. This comprehensive critique of instruments is important for nurses attempting to select a tool to guide optimum care for patients in the clinical setting.
BACKGROUND: Chemotherapy-induced nausea, vomiting, and retching are recognized as having an impact on patients' overall physical well-being, quality of life, and treatment decisions. Although there are many tools available to measure aspects of these symptoms, few offer a complete and concise clinical assessment. OBJECTIVE: The purpose of this article was to provide a comprehensive overview of the various instruments available for the assessment of cancer-related nausea, vomiting, and retching. Analysis included symptoms measured, period evaluated, type of questions posed, and aspects of each symptom measured. METHODS: Searches were conducted to find relevant articles using nationally recognized oncology Web sites and 4 electronic databases including PubMed, MEDLINE/CINAHL and CINAHL/EBSCO, and Cochrane. RESULTS: This review includes a total of 25 instruments that were identified as meeting the inclusion criteria of having been developed, or adapted, for the adult population, with an oncology focus. CONCLUSION: The ideal instrument would include measurement of all 3 symptoms while remaining clear, concise, and clinically relevant. IMPLICATIONS FOR PRACTICE: Although only 1 instrument came close to meeting these criteria, this review provides nurses with specific information on a variety of instruments to assist providers in selecting the most appropriate instrument for their specific clinical setting. This comprehensive critique of instruments is important for nurses attempting to select a tool to guide optimum care for patients in the clinical setting.
Authors: Catalina Hernandez Torres; Sasha Mazzarello; Terry Ng; George Dranitsaris; Brian Hutton; Stephanie Smith; Amy Munro; Carmel Jacobs; Mark Clemons Journal: Support Care Cancer Date: 2015-06-25 Impact factor: 3.603
Authors: Scott E Kanoski; Laura E Rupprecht; Samantha M Fortin; Bart C De Jonghe; Matthew R Hayes Journal: Neuropharmacology Date: 2011-12-28 Impact factor: 5.250
Authors: Wolfgang Marx; Alexandra L McCarthy; Karin Ried; Luis Vitetta; Daniel McKavanagh; Damien Thomson; Avni Sali; Liz Isenring Journal: BMC Complement Altern Med Date: 2014-04-09 Impact factor: 3.659